BetaBlue is an early stage biopharmaceutical company seeking to commercialize functionally selective ligands for the D2 dopamine receptor with the goal of improved efficacy in treating the negative and cognitive symptoms of schizophrenia. We are also pursuing development for dyskinesia & dystonia, substance use disorders, and Huntington's disease.
| Website | http://beta-blue.com/index.html |
| Revenue | $4 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2016 |
| Address | 8 The Grn Ste B, Dover, Delaware 19901, US |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+6 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Biopharmaceutical, Schizophrenia Treatment, Drug Development, Biotechnology, Drug Discovery, Mental Health, Therapeutics, Pharmaceutical Research, Neurological Disorders, Clinical Trials, Precision Medicine, Early Stage |
| Competitors | BlueOptima, Skytech, Inc, BlueCore Technologies, AERO SPECIALTIES CORP., BlueSky Technologies, BLUELINE TECHNOLOGY, BlueSphere Tech, DeepBlue Technologies, Techblue Solutions Private Limited, Nimbus IT Solutions +5 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular BetaBlue employee's phone or email?
BetaBlue Questions
The BetaBlue annual revenue was $4 million in 2026.
BetaBlue is based in Dover, Delaware.
The NAICS codes for BetaBlue are [32541, 325, 3254, 32].
The SIC codes for BetaBlue are [283, 28].
Related Companies
